Tania Kamal

I am an accomplished scientist with over 8 years of experience in biological and biomedical research laboratories and 2 years in diagnostic laboratories. I am skilled in molecular and immunology techniques following SOPs, regulatory compliance, and GLP guidelines. I have a proven ability to enhance laboratory efficiency through meticulous inventory management, problem-solving, and strong analytical skills. I can maintain a conscientious attitude in a laboratory by following health and safety protocols and utilising my knowledge of lab procedures to advance projects with rapidly changing priorities and timelines. Passionate about collaborative research and committed to achieving impactful results through critical thinking, communication, and teamwork.

Medical Laboratory Scientist, 30-11817, Medical Science Council of New Zealand, 01/01/18, present

• 2023, COVID-19 Response Recognition Awards, Te Whatu Ora - Health New Zealand
• 2016, Bursary in publication, University of Auckland
• 2016, University of Auckland Doctoral Scholarship extension, New Zealand
• 2015, Molecular Medicine and Pathology (MMP) travel grant, New Zealand
• 2015, University of Auckland Doctoral Scholarship extension, New Zealand
• 2013, Molecular Medicine and Pathology (MMP) travel grant, New Zealand
• 2013, Postgraduate Student Association (PGSA) travel grant, New Zealand
• 2012, The University of Auckland Doctoral Scholarship, New Zealand
• 2011, Ann and David Norman Doctoral Scholarship, New Zealand
• 2005-2007, Dong-Eui University foreign student scholarship, Korea
• 2002-2003, Ministry of National Science and Technology (NST) fellowship, Bangladesh
• 1996-2000, University Grant Commission (UGC) for academic excellence, Bangladesh

• 5th Asia-Pacific Summit on Cancer Therapy, Brisbane, Australia, 2015
• Conference on the Cell Biology of Megakaryocytes and Platelets, Lucca (Barga), Italy, 2015
• Medical Sciences Congress, Queenstown, 2013
• The XXIV congress of the international society of thrombosis and haemostasis (ISTH), Amsterdam, Netherlands, 2013
• Haematology Society of Australia and New Zealand Annual Meeting, Melbourne, Australia, 2012
• Endocrine Society Annual Meeting, San Francisco, US, 06/01/08
• 2022, The Collaborative Institutional Training Initiative (CITI Program) - Basic/Refresher Course - Human Subjects Research
• 2022, Certificate For the completion of MPI Transitional and Containment Facility
• 2013, Research Induction Course run by School of Medicine
• 2012, Polychromatic flow cytometry for the characterisation of hematopoietic and non-hematopoietic cells for clinical use Flow Cytometry Workshop

• Simulation of MICROBACT strip assay using colored liquids to demonstrate identification of unknown gram-negative organisms in undergraduate laboratory, Latifa B. Khan, Simon Swift, Tania Kamal, Hannah M. Read, Journal of Microbiology & Biology Education, 06/01/18, 19, 2
• N-methyl-d-aspartate receptor-mediated calcium influx supports in vitro differentiation of normal mouse megakaryocytes but proliferation of leukemic cell lines, Tania Kamal, Taryn N. Green, James I. Hearn, Emma C. Josefsson, Marie-Christine Morel-Kopp, Christopher M. Ward, Matthew J. During, Maggie L. Kalev-Zylinska, Research and Practice in Thrombosis and Haemostasis, 2017, 2, 1, 125-138
• Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation, Kamal T, Green TN, Morel-Kopp MC, Ward CM, McGregor AL, McGlashan SR, Bohlander SK, Browett PJ, Teague L, During MJ, Skerry TM, Josefsson EC, Kalev-Zylinska ML, Cellular Signalling, 2015, 27, 1860-1872
• A novel mechanism of calcium entry that increases growth of leukaemic megakaryoblasts, Kamal T, Green TN, Morel-Kopp MC, Ward CM, Skerry TM, Josefsson EC, Kalev-Zylinska ML, 5th Asia-Pacific Summit on Cancer Therapy, Brisbane, Australia, 2015, BEST POSTER AWARD
• Impact of glutamate-mediated calcium pathways on the growth of leukaemic megakaryoblasts, Kamal T, Green TN, Morel-Kopp MC, Ward CM, During MJ, Teague L, Browett PJ, Kalev-Zylinska ML, Gordon Conference on the Cell Biology of Megakaryocytes and Platelets, Lucca (Barga), Italy, 2015
• Can glutamate pathways influence neoplastic megakaryopoiesis?, Kamal T, Green TN, Morel-Kopp MC, Ward CM, During MJ, Teague L, Browett PJ, Kalev-Zylinska ML, New Directions in Leukaemia Research, Noosa, Queensland, Australia, 2014
• Glutamate pathways appear functional in human megakaryocytic cells, Kamal T, Green TN, Leung E, McGregor AL, B Baguley, Kalev-Zylinska ML, Medical Sciences Congress, Queenstown, 2013
• Megakaryocyte regulatory pathway mediated by NMDA receptors, Kamal T, Green TN, Morel-Kopp MC, Teague L, Browett PJ, During MJ, Kalev-Zylinska ML, The XXIV Congress of the International Society on Thrombosis and Haemostasis (ISTH), Amsterdam, Netherlands, 2013
• A maternal high fat diet either preconceptionally and/or throughout pregnancy and lactation leads to obesity in offspring independent of postnatal diet, Howie G, Sloboda DM, Kamal T, Vickers MH, The Journal of Physiology, 02/01/09, 587, 905-91
• Optimal Milieu for Culturing Porcine Sertoli Cell, Md. Anower Jabed, Tania Kamal, Byung-Ki Kim, Reproductive and Developmental Biology, 2006, 30, 3, 140-145
• In Vitro Maturation of Round Spermatids in Porcine Oviduct Epithelial Cell Monolayer Condition, Md. Anower Jabed, Tania Kamal, Seung-Min Lee, Byung-Ki Kim, Reproductive and Developmental Biology, 2005, 29, 4, 241-245

Medical Laboratory Scientist (registration no. 30-11817) with current APC, Medical Sciences

Council of New Zealand (2018-present)

· Lauren Jelley, Senior Scientist, Virus Identification Reference Laboratory, Institute of Environmental Science and Research Limited (ESR), Willington, New Zealand, +64 221357100, Lauren.Jelley@esr.cri.nz

· Dr Prasanna Kumar Kallingappa, Lead Technologist, University of Auckland, Department of Molecular Medicine and Pathology, Faculty of Medical and Health Science, Auckland, 1023, New Zealand, +64 211578057, p.kallingappa@auckland.ac.nz

· 2022: The Collaborative Institutional Training Initiative (CITI Program)

I have completed the following CITI Program course under requirements set by: Basic/Refresher Course - Human Subjects Research (Curriculum Group) HSP Group 1. Bio-medical (Course Learner Group) 1 - Basic Course (Stage) - Good Clinical Practice (GCP) (Curriculum Group) Good Clinical Practice for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA) (Course Learner Group) 1 - GCP (Stage) St. Jude Children's Research Hospital

· 2022: Certificate For the completion of MPI Transitional and Containment Facility

· 2013: Research Induction Course run by the School of Medicine

Keys include Keys to Success with Funding, Conducting Systematic Review and Meta‐Analysis, Successful Academic Publishing, Translational Research, Statistical Methods in Research, Tips for Successful Presentation.

· 2012: Polychromatic flow cytometry for the characterisation of hematopoietic and non-hematopoietic cells for clinical use Flow Cytometry Workshop